Literature DB >> 8438044

Echocardiography in chronic heart failure in the community.

N M Wheeldon1, T M MacDonald, C J Flucker, A D McKendrick, D G McDevitt, A D Struthers.   

Abstract

A total of 128 patients from a single practice population who were receiving loop diuretics for treatment of presumptive cardiac failure were identified from prescribing data captured by the Medicines Monitoring Unit. A subgroup of 78 patients underwent echocardiography to determine the prevalence of true left ventricular systolic dysfunction in this population and the validity of the diagnosis of cardiac failure in primary care. A further 50 patients were studied to assess the workload generated by these patients for both primary health care and hospital services. The estimated prevalence of left ventricular systolic dysfunction was 0.84%, whereas 1.6% of the population received loop diuretics for this indication. A false-positive diagnosis occurred in 47% and was more likely in females (73%) than males (37%). Of all consultations 79% were seen by GPs, 14% as hospital out-patients and 7% as in-patients. Within the hospital general physicians have most contact with these patients. In summary chronic heart failure is common within the community, although the false-positive rate for diagnosis of this condition is high. GPs and general physicians treat the majority of these patients and should therefore receive continuing education regarding recent advances in this area. Echocardiography should be performed early in the management of all patients suspected of having cardiac failure.

Entities:  

Mesh:

Year:  1993        PMID: 8438044

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  64 in total

1.  The scale of heart failure: diagnosis and management issues for primary care.

Authors:  F D Hobbs
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

2.  Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study.

Authors:  M J Landray; R Lehman; I Arnold
Journal:  BMJ       Date:  2000-04-08

3.  Quality issues for echocardiography in the community.

Authors:  S Saltissi; J Chambers
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

Review 4.  Central role of echocardiography in the diagnosis and assessment of heart failure. British Society of Echocardiography.

Authors:  M G Cheesman; G Leech; J Chambers; M J Monaghan; P Nihoyannopoulos
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

Review 5.  Diagnosis of heart failure in primary care: an assessment of international guidelines.

Authors:  G M Grimshaw; K Khunti; R Baker
Journal:  Br J Gen Pract       Date:  2001-05       Impact factor: 5.386

6.  The diagnosis of heart failure.

Authors:  A D Struthers
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

7.  The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.

Authors:  Ahmet Fuat; Jeremy J Murphy; A Pali S Hungin; Jane Curry; Ali A Mehrzad; Andrew Hetherington; Jennifer I Johnston; W Stuart A Smellie; Victoria Duffy; Patricia Cawley
Journal:  Br J Gen Pract       Date:  2006-05       Impact factor: 5.386

8.  Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial.

Authors:  S D Hutcheon; N D Gillespie; I K Crombie; A D Struthers; M E T McMurdo
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

9.  Role of echocardiography in the evaluation of syncope: a prospective study.

Authors:  F P Sarasin; A-F Junod; D Carballo; S Slama; P-F Unger; M Louis-Simonet
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

10.  Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.

Authors:  S J McClure; L Caruana; A P Davie; S Goldthorp; J J McMurray
Journal:  BMJ       Date:  1998-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.